Cilastatin
- Level
- Commodity
- Parent
- 51285900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51285902This classification denotes a protease inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 141A6AMN38. European Medicines Agency schedules Cilastatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06264MIG. Cilastatin generally arises in the molecular formula C16H26N2O5S. The term CILASTATIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 38, no. 6, 1984, list 24.) CILASTATIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O=C(N/C(=C\CCC)C(=O)O)C1C(C1)(C)C.
Same parent
Under 51285900 · 8Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.